Jaime Bald

1.4k citations
10 papers · 935 · 1 hit paper · h-index 8

Impact in

  • Hematology top 1%
    • Multiple Myeloma Research and Treatments
  • Physiology top 5%
    • Calcium signaling and nucleotide metabolism

Papers in

    • Multiple Myeloma Research and Treatments 7
    • CAR-T cell therapy research 4
    • Cancer Immunotherapy and Biomarkers 1

Jaime Bald

10 papers receiving 926 citations

Jaime Bald's Hit Papers

Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma 2016 · 673 citations
6730+3+6Years since publication200400600

Peers

Jaime Bald
Comparison fields: 5 of 58
  • Hematology 634
  • Physiology 87
  • Oncology 412
  • Genetics 123
  • Immunology 236
Replace Jakub Krejcik with:
Jakub Krejcik Denmark
Daniëlle C.H. Jacobs Netherlands
Thomas G. Martin United States
Larysa Sanchez United States
Irene Manrique Spain
Antonio Ortiz Buijsse Netherlands
Cristina Bugarin Italy
Kristine A. Frerichs Netherlands
Luis Palomera Spain
Anna Korycka Poland
Jaime Bald relative to Jakub Krejcik Denmark Jakub Krejcik's profile →
Citations per field
00.5×1.5×
Jakub Krejcik · 1×
Citations per year

Countries citing papers authored by Jaime Bald

Since Specialization
Citations

This map shows the geographic impact of Jaime Bald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime Bald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime Bald more than expected).

Fields of papers citing papers by Jaime Bald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaime Bald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime Bald. The network helps show where Jaime Bald may publish in the future.

Co-authors

The 25 scholars most cited alongside Jaime Bald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jaime Bald Line = papers co-authored together Jaime Bald links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
Hit paper breakdown →
2016673
2 201897
3 201686
4 201630
5 201516
6 20169
7 20158
8 20177
9 19747
10 20152

About Jaime Bald

Jaime Bald is a scholar working on Hematology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Genetics, having authored 10 papers that have together received 935 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Fluorine in Organic Chemistry (1 paper) and Quinazolinone synthesis and applications (1 paper). The work is most often cited by research in Hematology (634 citations), Physiology (87 citations), Oncology (412 citations), Genetics (123 citations) and Immunology (236 citations). Jaime Bald has collaborated with scholars based in United States, Belgium and Denmark. Frequent co-authors include Torben Plesner, A. Kate Sasser, Niels W.C.J. van de Donk, Tahamtan Ahmadi, Tineke Casneuf, Henk M. Lokhorst, Jakub Krejcik, Tuna Mutis, Inger S. Nijhof and Bie Verbist. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Chemistry and Laboratory Medicine (CCLM), Cancer Research and Cytometry Part A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact